SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations

SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations is a high-purity, anionic cyclodextrin derivative specifically developed for injectable and parenteral pharmaceutical formulations only. This injectable-grade excipient is widely used as a solubilizer and stabilizer for poorly water-soluble active pharmaceutical ingredients (APIs) intended for parenteral administration.

Through the formation of stable, non-covalent inclusion complexes, SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations significantly improves drug solubility and formulation stability while reducing precipitation risks during injection. This cyclodextrin derivative also helps minimize hemolysis and reduce renal toxicity, supporting safer and more reliable injectable drug delivery.

SBECD Betadex Sulfobutyl Ether Sodium is suitable for intravenous and other parenteral dosage forms. Due to its excellent water solubility, biocompatibility, and safety profile, this injectable pharmaceutical excipient has been widely adopted in complex parenteral formulations where solubility enhancement and patient safety are critical.

In global pharmaceutical practice, SBECD Betadex Sulfobutyl Ether Sodium has been successfully applied in several marketed injectable products, including Remdesivir Injection, Melphalan Hydrochloride for Injection, Posaconazole Injection, Ziprasidone Mesylate Injection, and Voriconazole Injection. These applications demonstrate the established performance of SBECD in enhancing solubility and stability for challenging injectable APIs.

Company Introduction

Xi'an DELI Biochemical Industry Co., Ltd. was established in 1999 and has more than 26 years of experience in the research, production, and supply of cyclodextrin derivatives. The company focuses on pharmaceutical excipients, including SBECD Betadex Sulfobutyl Ether Sodium and Hydroxypropyl Betadex (HPBCD), serving global pharmaceutical customers.

Xi'an DELI Biochemical operates dedicated clean production areas and strict quality control systems to ensure batch-to-batch consistency and regulatory compliance. Complete documentation, including COA, technical data, and formulation support, is available to support injectable drug development from R&D to commercial scale.

Product Specifications

CAS No: 182410-00-0

Molecular Formula: C42H70-nO35·(C4H8SO3Na)n

Grade: Injectable pharmaceutical excipient, EP and USP compliant

Appearance: White to off-white amorphous powder

Assay: ≥99.0%

Applications: Injectable and parenteral pharmaceutical formulations

Packaging: 500g/bag; 1kg/bag; 10kg/bag; 10kg/drum; customized packaging available

Storage: Sealed and stored in a dry place

Shelf Life: 36 months

FAQ

Q: Is Xi'an DELI Biochemical the manufacturer of SBECD Betadex Sulfobutyl Ether Sodium?

A: Yes, Xi'an DELI Biochemical produces SBECD Betadex Sulfobutyl Ether Sodium and Hydroxypropyl Betadex. Beta Cyclodextrin is used as the raw material for derivative production.

Q: Are samples available for evaluation?

A: Yes, samples of SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations are available upon request.

Q: What is the production capacity?

A: Batch production capacity is 2.5 tons, with an annual output exceeding 200 tons.

Q: What documents can be provided?

A: COA, MSDS, stability data, and technical dossiers are available for each batch.

Q: What shipping methods are available?

A: Global shipping is available by air, sea, or express courier.

Inquiry & Technical Support

Contact Xi'an DELI Biochemical for samples, technical information, or quotations for SBECD Betadex Sulfobutyl Ether Sodium for Injectable Formulations. Our technical team is ready to support your injectable formulation development with stable supply and professional service.